Shandong Xinhua Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
578.00
587.00
548.00
508.00
465.00
435.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-823.00
-968.00
-331.00
-666.00
-433.00
-495.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
407.00
302.00
890.00
323.00
287.00
310.00
Cash Flow from Investing Activities
-238.00
-346.00
-231.00
-276.00
-325.00
-498.00
Cash Flow from Financing Activities
200.00
-216.00
-195.00
-189.00
214.00
62.00
Net Cash Inflow / Outflow
385.00
-253.00
481.00
-152.00
162.00
-124.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
16.00
7.00
18.00
-9.00
-13.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shandong Xinhua Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
578.428109089918
29.1752719152816
549.00
1882.60%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-823.056719234936
227.979117290394
-1,050.00
-461.02%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
407.443349829474
265.308483656456
142.00
53.57%
Cash Flow from Investing Activities
-238.955261391302
-1.77907515289762
-237.00
-13331.43%
Cash Flow from Financing Activities
200.341335709922
-52.8962739539166
252.00
478.74%
Net Cash Inflow / Outflow
385.106285414138
206.755062834773
179.00
86.26%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
16.2768612660459
-3.87807171486894
19.00
519.72%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 34.85% vs -66.09% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
407.44
302.16
34.85%






